Oncternal Therapeutics (NASDAQ:ONCT) Earns Hold Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Wednesday. The firm issued a hold rating on the stock. Several other equities research analysts have also recently issued reports on the company. HC Wainwright decreased their price objective on Oncternal Therapeutics from $19.00 to $18.00 and […]
5 Oct 19:26 · The Cerbat Gem